Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Journal of Gastroenterology
Published in: Journal of Gastroenterology 1/2005

01-01-2005

Soluble CD163 in patients with liver diseases: very high levels of soluble CD163 in patients with fulminant hepatic failure

Authors: Atsushi Hiraoka, Norio Horiike, Sk. Md. Fazle Akbar, Kojiro Michitaka, Takami Matsuyama, Morikazu Onji

Published in: Journal of Gastroenterology | Issue 1/2005

Login to get access
Metadata
Title
Soluble CD163 in patients with liver diseases: very high levels of soluble CD163 in patients with fulminant hepatic failure
Authors
Atsushi Hiraoka
Norio Horiike
Sk. Md. Fazle Akbar
Kojiro Michitaka
Takami Matsuyama
Morikazu Onji
Publication date
01-01-2005
Publisher
Springer-Verlag
Published in
Journal of Gastroenterology / Issue 1/2005
Print ISSN: 0944-1174
Electronic ISSN: 1435-5922
DOI
https://doi.org/10.1007/s00535-004-1493-8

Other articles of this Issue 1/2005

Journal of Gastroenterology 1/2005 Go to the issue

Letters to the editor

Hyperammonemia-induced encephalopathy due to ornithine transcarbamylase deficiency in an adult woman: identification of novel missense mutations

Case report

Helicobacter heilmannii infection in a child after successful eradication of Helicobacter pylori: case report and review of literature

OriginalPaper

Pulmonary blood transit time and impaired arterial oxygenation in patients with chronic liver disease

OriginalPaper

Prognostic factors in patients with advanced hepatocellular carcinoma receiving hepatic arterial infusion chemotherapy

Review

Significance of apoptotic cell death in systemic complications with severe acute pancreatitis

Editorial

Genetic changes in the interferon sensitivity-determining region of hepatitis C virus (HCV) during the natural course of infection: an implication for the gene function in the role of chronic infection
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits